Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Neyssa Marina's publication output changed over time?
ScholarIQpublication output · 2004–2021
Output declined50% over the shown period — from 2 works in 2004 to 1 in 2021.
2
1
1
1
1
1
1
1
1
1
2004200620092013201420152016201820192021
What are the most-cited papers on Neyssa Marina?
ScholarIQmost cited works
Chronic Health Conditions in Adult Survivors of Childhood Cancer
Kevin C. Oeffinger, Ann Mertens, Charles A. Sklar, Toana Kawashima, Melissa M. Hudson, Anna T. Meadows, Debra L. Friedman, Neyssa Marina, Wendy L. Hobbie, Nina S. Kadan‐Lottick, Cindy L. Schwartz, Wendy M. Leisenring, Leslie L. Robison
New England Journal of Medicine. 20063,617 Citations
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
Sigbjørn Smeland, Stefan Bielack, Jeremy Whelan, Mark L. Bernstein, Pancras C.W. Hogendoorn, Mark Krailo, Richard Görlick, Katherine A. Janeway, Fiona C. Ingleby, Jakob Anninga, Imre Antal, Carola Arndt, Ken Brown, Trude Butterfaß‐Bahloul, Gabriele Calaminus, Michael Capra, Catharina Dhooge, Mikael Eriksson, Adrienne M. Flanagan, Godehard Friedel, Mark C. Gebhardt, Hans Gelderblom, Robert E. Goldsby, Holcombe E. Grier, R. J. Grimer, Douglas S. Hawkins, Stefanie Hecker‐Nolting, Kirsten Sundby Hall, Michael S. Isakoff, Gordana Jovic, Thomas Kühne, Leo Kager, Thekla von Kalle, Edita Kabíčková, Susanna Lang, Ching C. Lau, Patrick J. Leavey, Stephen L. Lessnick, Leo Mascarenhas, Regine Mayer‐Steinacker, Paul A. Meyers, Raj Nagarajan, R. Lor Randall, Peter Reichardt, Marleen Renard, Catherine Rechnitzer, Cindy L. Schwartz, Sandra J. Strauss, Lisa A. Teot, Beate Timmermann, Matthew R. Sydes, Neyssa Marina
European Journal of Cancer. 2019732 CitationsOPEN ACCESS
Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines From the Children's Oncology Group Late Effects Committee and Nursing Discipline
Wendy Landier, Smita Bhatia, Debra A. Eshelman, Katherine J. Forte, Teresa Sweeney, Allison L. Hester, Joan Darling, F. Daniel Armstrong, Julie Blatt, Louis S. Constine, Carolyn Freeman, Debra L. Friedman, Daniel M. Green, Neyssa Marina, Anna T. Meadows, Joseph P. Neglia, Kevin C. Oeffinger, Leslie L. Robison, Kathleen S. Ruccione, Charles A. Sklar, Melissa M. Hudson
Journal of Clinical Oncology. 2004713 Citations
Biology and Therapeutic Advances for Pediatric Osteosarcoma
Neyssa Marina, Mark C. Gebhardt, Lisa A. Teot, Richard Görlick
The Oncologist. 2004664 Citations
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
Neyssa Marina, Sigbjørn Smeland, Stefan Bielack, Mark L. Bernstein, Gordana Jovic, Mark Krailo, Jane Hook, Carola Arndt, Henk van den Berg, Bernadette Brennan, Bénédicte Brichard, Ken Brown, Trude Butterfaß‐Bahloul, Gabriele Calaminus, Heike E. Daldrup‐Link, Mikael Eriksson, Mark C. Gebhardt, Hans Gelderblom, Joachim Gerß, Robert E. Goldsby, Allen M. Goorin, Richard Görlick, Holcombe E. Grier, Juliet Hale, Kirsten Sundby Hall, Jendrik Hardes, Douglas S. Hawkins, K. Helmke, Pancras C.W. Hogendoorn, Michael S. Isakoff, Katherine A. Janeway, Heribert Jürgens, Leo Kager, Thomas Kühne, Ching C. Lau, Patrick J. Leavey, Stephen L. Lessnick, Leo Mascarenhas, Paul A. Meyers, Hubert Mottl, Michaela Nathrath, Zsuzsanna Pápai, R. Lor Randall, Peter Reichardt, Marleen Renard, Akmal Safwat, Cindy L. Schwartz, Michaël C.G. Stevens, Sandra J. Strauss, Lisa A. Teot, Mathias Werner, Matthew R. Sydes, Jeremy Whelan
The Lancet Oncology. 2016546 CitationsOPEN ACCESS
Related on ScholarIQ
Coherus BioSciences (United States)
Institution
Chronic Health Conditions in Adult Survivors of Childhood Cancer
Paper
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
Paper
Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines From the Children's Oncology Group Late Effects Committee and Nursing Discipline
Paper
Biology and Therapeutic Advances for Pediatric Osteosarcoma
Paper
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
Paper